View More Recent Stories
-
Jazz Pharmaceuticals (JAZZ) PT Lowered to $174 at RBC Capital
-
Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 53c
-
Jazz Pharmaceuticals (JAZZ) Appoints Laura Hamill to its Board
-
Jazz Pharmaceuticals (JAZZ) Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for Certain Notes
-
Jazz Pharmaceuticals (JAZZ) Promotes Samantha Pearce to Chief Commercial Officer
-
Jazz Pharmaceuticals (JAZZ) PT Lowered to $113 at UBS
-
Jazz Pharmaceuticals (JAZZ) Reports Phase 2b Trial of JZP385 Did not Meet Endpoints
